The second article of the series addresses the long-term incidence and risk factors for development of spinal deformity in the same patient population. 1 
Methods
Patients with a histopathological diagnosis of intramedullary tumor in the pediatric age group (< 21 years at presentation) were identified through a retrospective search of the neurosurgery inpatient database at the University of Iowa Hospitals and Clinics for the time period from January 1975 to January 2010. Patient records were reviewed for: 1) patient demographic characteristics, 2) clinical presentation, 3) surgical treatment, 4) chemotherapy and/or radiation therapy received, and 5) final clinical outcomes (based on clinical and radiographic evaluation by the Neurosurgery, Pediatric Oncology, and Pediatric Orthopedic Services). The senior author (A.H.M.) was the primary surgeon for most of the patients.
Preoperative and postoperative functional assessment was performed using the modified McCormick functional scale, 29, 31 with grades defined as follows: Grade I, neurologically intact with normal gait with or without mild focal deficit; Grade II, independent ambulation and functioning in presence of sensorimotor deficit with mild to moderate gait difficulty; Grade III, independent with external aid with moderate neurological deficit; Grade IV, functional dependence with severe moderate to severe deficits; and Grade V, paraplegic or quadriplegic requiring wheelchair with upper-extremity impairment. Imaging characteristics of the tumor were determined through preoperative CT myelography (when applicable) and MRI. Baseline and follow-up radiographic assessment of skeletal deformity was undertaken in consultation with the Pediatric Orthopedic Service.
Operative Technique
An osteoplastic laminoplasty was planned in all children unless preoperative imaging studies indicated significant mass effect that necessitated extensive decompression, often with the aid of a fascial graft, or in instances when preoperative imaging studies indicated a high probability of incomplete resection given a lack of clearly defined tumor margins. Neurophysiological monitoring with somatosensory evoked potentials was used in the last 3 decades; motor evoked potentials were adjuncts used in the last decade.
Intraoperative ultrasonography was used to identify the tumor and any accompanying syrinx cavities. A midline myelotomy was performed, spanning the levels involved by tumor. Initial biopsies were obtained from the areas that showed the most enhancement on preoperative MR imaging. Tumor debulking was initiated at the caudal end of the tumor, usually within the syrinx cavity. This was aided by high-powered microscopy and microsurgical technique with suction, ultrasonic aspiration, and cottonoid patty wisps soaked with thrombin. Bipolar cautery was infrequently needed. Circumferential dissection was extended in all planes where a distinct tumor-spinal cord interface could be identified. The mean arterial pressure was monitored carefully and maintained above 70 mm Hg (this is critical), with vasopressor support as needed. In our opinion, laminoplasty is advantageous in aiding future instrumentation if needed, improving wound healing, and preventing CSF leaks.
Surgical records were reviewed to determine surgical approach, degree of resection, and additional intraoperative surgical findings. Degree of resection was determined through intraoperative assessment of tumor removal and verified by means of MR images obtained 1-3 days after surgery. Tumor resection was classified as GTR if the surgeon's and radiographic assessment were in agreement. In all other cases, subtotal resection (STR) was determined to have occurred. If laminectomy was performed at C-7 or T-1, the cervicothoracic junction was considered to be involved. If it was performed at T-12 or L-1, the thoracolumbar junction was considered to be involved. The score for deficit on presentation was calculated based on the presence or absence of motor, sensory, bladder, or bowel deficits, with the presence of each deficit counting for 1 point, such that the scores could range from 0 (no deficits) to 4 (deficits in each category).
Patients were also followed up in consultation with the Pediatric Oncology and Radiation Oncology Services to determine whether adjunctive therapy should be administered. The University of Iowa Human Subjects Office Institutional Review Board approved this retrospective study.
Statistical Analysis
Descriptive data were presented as proportions and means with standard error of means (mean ± SEM). Univariate analysis for all outcomes analysis was performed using the Pearson chi-square test and logistic regression. Statistical significance for both uni-and multivariate analyses was set at p < 0.05. Progression-free survival (PFS) and OS (defined as disease survival) rates were estimated by Kaplan-Meier survival estimates and 95% confidence intervals. Multivariate analysis of survival was done by means of survival regression using the underlying Weibull distribution. Goodness of fit was assessed by means of survival graphs, log-survival plots, and Schoenfeld residual plots to assess proportionality. Variables with univariate p values < 0.1 were then entered into a survival regression model for multivariate analysis. The survival assumption was verified. Input variables that had p values < 0.05 after this analysis were reported as being statistically significant on multivariate analysis. All statistical analysis was performed using SAS software version 9.3.
Results

Clinical Demographics
A total of 55 patients (30 male and 25 female) were identified who were treated during the study period (January 1975 to January 2010) ( Table 1) . Forty-seven patients (85%) presented to our service for primary treatment, and 8 patients (15%) had a history of prior surgical treatment. Magnetic resonance imaging was available for imaging on initial presentation for 44 patients (80%); CT myelog-raphy was used for diagnostic imaging in the remaining 11 patients (20%).
Sensory deficits were the most common presenting symptom (present in 42 cases within the study population. In 40 (91%) of the 44 cases in which MRI was used for initial imaging, the tumors showed contrast enhancement. The tumor margins were well defined radiologically in 15 (34%) of these cases; in the remaining 29 cases (66%), the tumors had diffuse, illdefined borders on preoperative imaging.
Surgical Treatment
Surgery resulted in GTR in 21 patients (38%) and STR in the remaining 34 patients (62%) ( Table 2 ). The overall incidence of surgical complications was 5% (3 cases: wound infection in 2 cases and delayed wound healing in 1 case). There were no intra-or postoperative deaths related to surgical intervention. In all, 12 patients (22%) developed hydrocephalus requiring ventriculoperitoneal shunt placement (in 9 cases) or significant syringomyelia that necessitated syrinx-subarachnoid shunt insertion (in 3).
Postoperative Neurological Status
Within the immediate postoperative period, the overall incidence of new-onset neurological deficit or progression of preexisting neurological deficit was 27% (15 cases) ( Table 2 ). Progression of underlying motor deficit or development of new-onset motor symptoms occurred in 11 patients (20%). Of these 11 patients, 7 (63%) demonstrated neurological improvement during the follow-up period (median time from surgery to neurological improvement: 3 months). Underlying disease progression led to continued motor decline in 3 (27%) of these patients. Similarly, new-onset or progressive sensory deficits were encountered in 8 patients (14.5%) within the postoperative period. Neurological recovery was noted in 4 (50%) of these 8 (median 7 months postoperatively). The remaining patients showed disease progression with continued decline in overall neurological function. The incidence of newonset bowel or bladder dysfunction was 1.8% (1 case) and the incidence of progression in preexisting bowel or bladder deficit was 5.5% (3 cases), respectively.
Long-Term Neurological Outcomes
The mean time to neurological improvement (± SEM) was 4.4 ± 0.8 months (median 2.5 months, range 1.0-24 months). Postoperative neurological improvement was noted in 23 (70%) of the 33 patients with initial motor deficits, 27 (64%) of the 42 with sensory deficits, 4 (19%) of the 21 with bladder deficits, and 4 (40%) of the 10 with bowel deficits on presentation.
The mean duration of follow-up (± SEM) was 11.4 ± 1.3 years (median 9.3 years, range 0.2-37.2 years). By final follow-up, 30 patients (55%) showed neurological improvement and 17 (31%) showed neurological decline, while 8 (15%) remained neurologically stable (Table 3) (Table 4) .
Adjunct Therapy
Chemotherapy was used in 16 patients (29%). It was used as adjuvant therapy in 11 patients (20%) and for treatment of tumor recurrence or progression in 5 (9%). Radiotherapy was used in 28 patients (51%)-as adjuvant therapy in 23 patients (42%) and for treatment of tumor recurrence or progression in 5 patients (9%).
Survival and PFS Outcomes
Disease recurrence/progression was noted in 26 patients (47%). The mean time from the primary surgical procedure to the onset of recurrence or progression was 3 months. The Kaplan-Meier actuarial tumor PFS rates at 5, 10, and 20 years were 61% (95% CI 46%-72%), 54% (95% CI 39%-66%), and 44% (95% CI 27%-60%), respectively; OS rates were 85% (95% CI 75%-95%) at 5 years, 74% (95% CI 61%-87%) at 10 years, and 64% (95% CI 46%-82%) at 20 years (Table 2 and Fig. 1 ).
On analyzing predictors for OS, the following variables were found to be significant on univariate analysis: tumor grade, functional grade on presentation and initial discharge, resection, shunt placement, use of chemo-and/ or radiotherapy, and number of tumor surgeries. On multivariate analysis, GTR (hazard ratio [HR] 8.83, p < 0.04), tumor grade (HR 0.24, p = 0.02), and number of tumor resections (HR 0.26, p = 0.03) were found to be predictive of long-term survival (Table 5 and Fig. 2 ). The 10-year OS rate was 61% (95% CI 42%-80%) in patients who underwent STR as compared with 94% (95% CI 84%-100%) in patients who underwent GTR. Similarly, the 10-year OS was 82.3% (95% CI 67%-93%) in patients with low-grade tumors in comparison with 51% (95% CI 18%-77%) in patients with high-grade tumors. For the patients who underwent only 1 tumor resection procedure, the 10-year OS was 87% (95% CI 72%-95%) as compared with patients who underwent more than 1 resection procedure, for whom the OS was 48% (95% CI 25%-75%). Functional grade on presentation, resection, shunt placement, use of chemo-and/or radiotherapy, and number of tumor surgeries were found to be predictive of long-term PFS on univariate analysis. Only number of tumor resections > 1 (HR 8.7, p = 0.01) significantly correlated with PFS on multivariate analysis (Table 6) .
We also analyzed determinants of short-term (5-year) PFS. On multivariate analysis, GTR (HR 4.59, p = 0.01), use of radiation therapy (HR 0.33, p = 0.04), and preoperative functional Grades III and IV (HR 8.37, p < 0.01) were significantly correlated with 5-year PFS. Of these 3 factors, only GTR led to improved 5-year PFS (86% 5-year PFS in patients who had GTR as compared with 47% 5-year PFS in patients who had STR; multivariate p = 0.04; Kaplan-Meier analysis). Inclusion of radiation therapy was associated with lower 5-year PFS (57% in patients who received radiation therapy as compared with 19% those who did not receive any adjuvant or delayed radiation therapy) and represents an inherent selection bias.
We found no correlation between any of the clinical or treatment factors and functional improvement by the last follow-up.
Discussion
Optimal management of pediatric IMSCTs entails careful consideration of management options, given the lifetime morbidity of neurological disease in pediatric patients. Considerations include the natural history of primary disease following resection, iatrogenic risk of neurological progression following surgery, developmental and biomechanical immaturity of the pediatric spine, and susceptibility of the developing nervous system to adjunct chemo-radiotherapy treatments. Our results provide an overview of the long disease course and outcomes in pediatric patients with intramedullary tumors following treatment through direct follow-up extending beyond the 1st decade after treatment for the first time. We have further identified demographic, clinical, and treatment factors that predict neurological improvement and disease outcomes on longterm follow-up. Our results indicate that favorable (74% at 10 years and 63% at 20 years) long-term OS rates may be observed in the pediatric population with intramedullary tumors. On multivariate analysis, extent of resection is the most significant predictor of extended long-term survival and 5-year PFS. Functional improvement was observed in approximately 50% of all patients by last follow-up and was even seen in patients initially presenting with the worst functional status (Grades IV-V). Although the fact that this study is a single-institution case series might be seen as a limitation, it minimizes bias due to patient selection and treatment. In contrast to previous studies, 4, 8, 23, 30, 51 this study reports on disease outcomes over an extended follow-up beyond the 1st decade after surgery and thereby serves to better define the disease course and treatment outcomes for pediatric IMSCTs.
Rates of Long-Term Disease Survival
In our series, the 10-year survival rate (74%) is consistent with that reported by Constantini et al. and also falls within the range of previous additional studies. 4, 38, 48 With a mean follow-up of approximately 11.5 years, we determined the 20-year disease survival rate to be 64%. Our extended follow-up enabled us to determine that up to 44% of patients were free of progression 20 years posttreatment. This indicates relatively favorable disease outcomes for a potentially debilitating disease affecting children and adolescents. These long-term follow-up results therefore provide the first report of disease survival estimates beyond 1 decade posttreatment.
Determinants of Long-Term Survival
On univariate analysis, factors that significantly correlated with OS were functional status on presentation, histological grade, extent of resection, and CSF shunt placement. These factors have been observed to be predictive of OS in previous studies. Additional factors significant on univariate analysis included number of tumor surgeries and need for adjuvant therapy, which are surrogate markers for disease progression. On multivariate analysis, extent of resection, tumor histology grade, and number of tumor resection procedures were significantly predictive of long-term disease survival. 
Extent of Resection.
Since initially advocated, GTR remains the definitive surgical goal in the treatment of IMSCTs. 6, 11, 14 Results from previous studies have been ambiguous on the survival predictive value of resection, with some studies indicating improved long-term survival and neurological outcomes, 6, 13 while others support the role for limited resections followed by adjuvant therapies. 33, 36, 48 This discrepancy is in part attributed to the heterogeneity in surgical versus radiographic assessment of tumor resection and variability in defined surgical margins that often limits resection. 19, 25 The extent of tumor resection and benefits of GTR correlate with tumor histology. 16, 20, 23, 45 Low-grade pilocytic astrocytoma subtypes are much more likely to be associated with defined tumor margins than are higher-grade astrocytomas. This may also account for variability in reported rates of GTR for astrocytomas and hence confounds the predictive association between extent of resection and disease outcomes. [41] [42] [43] The overall GTR rate in our series (38%) was lower than that previously reported by some authors 4 but in line with the rate reported by others. 44 In contrast to earlier studies, 2, 33 our results support the beneficial role for GTR, where feasible, in long-term disease survival and prevention of disease progression over extended follow-up. 30 The predictive value of extent of resection was maintained across our cumulative case series. This finding is significant, since astrocytomas were the most prevalent histological subtype in our series and are frequently associated with indistinct tumor margins. Our results therefore emphasize the importance of resection in predicting long-term disease and neurological outcomes within the pediatric age group.
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In addition, extent of resection was also significantly associated with improved PFS in this study, in contrast to an earlier study that did not find an association between GTR and PFS in astrocytomas. 16 Of particular note, the survival advantage of GTR was maintained at the 5-year time point in contrast to an earlier report that indicated similar results for GTR and STR in terms of PFS beyond 3 years of follow-up. 4 Tumor Histology and Grade. Tumor grade was also significantly associated with disease survival outcome on multivariate analysis, in line with findings of earlier studies that describe the prognostic value of tumor grade. 17, 33 In contrast to earlier studies, however, we did not find any statistically significant association with histological subtype. 4, 23, 33 Tumor margins and hence extent of resection are directly related to tumor grade and histological subtype. Hence, our finding of the prognostic value of resection extent is an indirect reflection of this underlying association. This is supported by the observation that the major tumor histological subtype/grade were low-grade astrocytomas, ependymomas, and gangliogliomas, which are typically slow-growing and indolent tumors. 
Hydrocephalus and Syringomyelia
Development of symptomatic hydrocephalus and/or syringomyelia necessitating shunt placement was a significant factor in our group on univariate analysis. The associ ation between hydrocephalus and intramedullary tumors has been well described, both as a presenting symptom and as a manifestation of disease progression. 37, 49 Obstruction of CFS occurs through leptomeningeal disease in patients with high-grade tumors and secondary to altered CSF viscosity and tumor hemorrhage. 34, 39 Rostral extension of syringomyelia to the cervicomedullary junction can also cause hydrocephalus by mechanical obstruction of CSF outlet pathways in low-grade intramedullary tumors. The presence of syringomyelia in patients with low-grade tumors such as ependymomas and hemangioblastomas was not found to be associated with long-term disease outcomes. 41 Similarly, shunt placement was indirectly found to be negatively correlated with survival due to an association with high-grade lesions. 4 Importantly, hydrocephalus may precede or accompany development of neurological symptoms secondary to the underlying tumor and may also develop postoperatively. It often occurs with delayed onset, thereby mandating long-term radiological follow-up. 34 In our series, there was no significant association between tumor grade and incidence of secondary hydrocephalus and/or syringomyelia. We chose to categorize patients with secondary hydrocephalus and syringomyelia together for outcome analysis, since in our experience these conditions had a similar presentation, both required CSF diversion, and were both associated with a significant effect on longterm disease survival. In our opinion, the pathogenesis of secondary syringomyelia is a manifestation of obstruction of subarachnoid CSF drainage pathways within the spine-either due to local disease progression or as a consequence of tissue reparative mechanisms and scarring. This is supported by our clinical observations of neurological improvement following placement of syrinxsubarachnoid shunts.
Additional Factors Associated With OS and PFS
Age as Null Predictor. In our experience, age does not affect OS, disease progression, or the rate of functional improvement. This indicates that despite the potential morbidity associated with resection, surgery is well tolerated, and GTR, when safely feasible, should be the primary treatment goal. Hence, this mandates prompt tumor resection even in infants presenting with severe deficits. This is consistent with earlier studies. 4, 17, 46 Number of Tumor Resections. Overall survival was significantly lower in patients who underwent more than 1 tumor resection procedure as compared with patients who had 1 resection only (50% vs 82%, respectively). This reflects the greater rate of disease progression in the former group (81%) as compared with that of patients who had 1 resection (22%; Table 6 ).
Tumor Characteristics. We did not find any prognostic significance for additional tumor characteristics, such as preoperative syrinx, tumor margins, contrast enhancement, or spinal level. Significantly, longitudinal tumor span was not associated with adverse survival outcomes, indicating that even extensive multisegment intramedullary tumors can be resected with minimal adverse impact on disease survival, consistent with earlier reports. 10, 12, 47 
Natural History and Long-Term Neurological Outcomes Following Surgery
Clinical Presentation. In our pediatric series, the most common location for tumor presentation was the cervicomedullary junction (36%), followed by the thoracic spine (27%). Astrocytomas (53%) were the most prevalent histological subtype, consistent with earlier studies. 3, 4 Despite the pattern of contrast enhancement on MRI (91%), most of these tumors were low grade (78%). 8 Although the average time interval from symptom development to clinical presentation was 7 months, most patients (67%) presented with McCormick Grade I-II functional status. This underscores previous observations that, unlike their intracranial counterparts, intramedullary lowgrade gliomas should be primarily managed surgically on discovery to avoid any further neurological deterioration.
Rate of Improvement. Sensory deficits (76%) were the most prevalent type of neurological deficit on initial presentation, with motor symptoms (60%) next in prevalence. Most patients experienced improvement in their preoperative neurological deficit following resection. The prevalence of postoperative improvements was 70% and 64% for initial motor and sensory deficits, respectively. Improvement in preoperative bowel (40%) and bladder (9%) deficits were much less consistent. Overall, 55% of the study group experienced neurological improvement by the last clinical follow-up visit. This is within the range of previously reported rates of neurological improvement. 16, 51 Importantly, our extended follow-up enables us to conclude that our reported rates of neurological improvement are well maintained beyond the 1st decade postoperatively. Stratification by functional grade on presentation indicated that the rate of neurological improvement was in the range of 55%-63% for patients presenting with Grades I-II functional status and 50% for patients presenting with more severe grades, IV-V. Preoperative functional status was the only significant predictor of postoperative neurological improvement in our series, consistent with earlier studies. 23, 42, 50 Hence, we concur with Garcés-Ambrossi et al. 16 that neurological restoration rather than preservation 45 should be the treatment goal, especially in the pediatric age group.
Postoperative Neurological Decline. Despite widespread use of intraoperative neurophysiological monitoring, immediate postoperative neurological decline has been widely reported. 7, 28, 29 This has been attributed to operative manipulation of the dorsal columns during the surgical myelotomy and reactive tissue edema with temporary neuronal injury and may correlate with poorer preoperative neurological status. 14, 20 The incidence of new-onset neurological deficits and/or progression of preexisting deficits in the immediate postoperative period in our series was 27% (occurring in 15 of 55 cases). The majority of motor-related symptoms (63%) were transient (median time to resolution 3 months). Sensory deficits resolved postoperatively in 50% of cases (median time to resolution 7 months). This is consistent with previous reports. 19 
Role of Adjunct Therapy
The role of both chemo-and radiotherapy is ambiguous in the literature, with reports of indeterminate, improved, and no survival advantages conferred by these adjuncts. 2, 9, 22, 26, 32, 33, 36, 44, 46 The overall rate of tumor progression in our series was 47%, with a mean onset of 3 years postoperatively (mean [± SEM] 3.3 ± 1 years, range 0.1-20 years). Radiotherapy was used following disease progression or recurrence in 51% of the 55 patients, while chemotherapy was used in 29% of the patients. The independent survival and/or treatment benefit of these adjunct therapies could not be determined for lack of randomization of treatment modalities inherent to retrospective reviews. In our study group, inclusion of adjuvant therapies did not significantly improve OS. Inclusion of radiotherapy was statistically associated with 5-year PFS and represents an intrinsic selection bias because patients receiving radiotherapy are at high risk of disease progression.
Conclusions
Assessments of long-term OS and disease progression in children with intramedullary tumors show that GTR and tumor grade are the most significant factors in survival. Moreover, the survival advantages conferred by GTR appear to sustain beyond the 1st decade after treatment. Gross-total resection was associated with improved PFS at 5 years. Kaplan-Meier analysis showed the rate of PFS to be 44% for as long as 2 decades postoperatively. Long-term follow-up also demonstrated prolonged OS, especially in patients in whom there was no sign of disease progression. Neurological improvement occurred in 55% of patients postoperatively and was sustained by surviving patients over long-term follow-up.
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